Skip to content

Polaryx Therapeutics, Inc. PLYX Other operating expenses

Other operating expenses at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$3.96M+303%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$12.32M+19.3%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$81.59M-11.8%
PVL
Palvella TherapeuticsPVLA
$14.86M+88.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$227.59M+10.6%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
0%0.0pp

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$132.59M-86.9%

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's other operating expenses?
Polaryx Therapeutics, Inc. (PLYX) reported other operating expenses of $1.96M in Q1 2026.
How has Polaryx Therapeutics, Inc. 's other operating expenses changed year-over-year?
Polaryx Therapeutics, Inc. 's other operating expenses decreased by 61.2% year-over-year, from $5.05M to $1.96M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.